Aristolochic D

Aristolochic D

SCHEMBL26801941

COc1cc(O)cc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 8/20 1.00
MEN1 O00255 3/20 0.75
KMT2A Q03164 3/20 0.75
ALDH1A1 P00352 3/20 0.75
SMN1; SMN2 Q16637 2/20 0.75
CYP3A4 P08684 1/20 0.75
MAPT P10636 1/20 0.75
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TPMT P51580 1/20 0.35
PKM P14618 1/20 0.35
ABCB1 P08183 1/20 0.35
MAPK1 P28482 1/20 0.34
NQO1 P15559 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aristolochic D SCHEMBL29588367 1.00 CDK2 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid Iv SCHEMBL29238593 0.90 CDK2 (0.82) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid SCHEMBL29518476 0.86 ALDH1A1 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid SCHEMBL29367530 0.86 ALDH1A1 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid SCHEMBL30825061 0.86 ALDH1A1 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid SCHEMBL166284 0.86 ALDH1A1 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid SCHEMBL15535358 0.85 ALDH1A1 (0.98) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
7-Hydroxy Aristolochic A SCHEMBL4557492 0.81 CDK2 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid C SCHEMBL30039516 0.79 CDK2 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2
Aristolochic Acid C SCHEMBL30697302 0.79 CDK2 (1.00) CDK2MEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230372288-A1 Application of Aristolochic Acid IVa in Preparation of Antihistamine or Drug for Treating Pneumonia INSTITUTE OF CHINESE MATERIA MEDICA, CHINA ACADEMY OF CHINESE MEDICAL SCIENCES (CN) 2023-11-23 US disclosed
CN-115969840-A Application of aristolochic acid IVa in preparing medicine for treating autoimmune disease 上海交通大学医学院 2023-04-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230372288-A1 Application of Aristolochic Acid IVa in Preparation of Antihistamine or Drug for Treating Pneumonia HRH4, HRH3, HRH2 CDK2 2978/4885MEN1 4773/4885KMT2A 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.